Revenue | ₹565.26Cr |
Net Profits | ₹54.22Cr |
Net Profit Margins | 9.59% |
Astrazeneca Pharma India Ltd’s revenue jumped 35.83% since last year same period to ₹565.26Cr in the Q2 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 5.15% jump in its revenue since last 3-months.
Astrazeneca Pharma India Ltd’s net profit jumped 41.09% since last year same period to ₹54.22Cr in the Q2 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -2.88% fall in its net profits since last 3-months.
Astrazeneca Pharma India Ltd’s net profit margin jumped 3.87% since last year same period to 9.59% in the Q2 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -7.64% fall in its net profit margins since last 3-months.
The revenue for Astrazeneca Pharma India Ltd in the Q2 results 2025 was ₹565.26Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q2 results 2025 was ₹54.22Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q2 results 2025 was 9.59%.
The revenue for Astrazeneca Pharma India Ltd in the Q2 results 2024 was ₹416.15Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q2 results 2024 was ₹38.43Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q2 results 2024 was 9.23%.